NEW YORK (
(WAVX - Get Report)
was one of several stocks trading near $5 poised to move on above-average volume Tuesday after the hardware-based digital-security company reported quarterly results.
said late Monday that it had a first-quarter net loss of a penny a share, compared to a year-ago loss of 2 cents a share. Revenue jumped 45% from a year ago to $5.86 million. Separately, the company said it has acquired two patents related to security subsystems for storage devices for $1.1 million in cash.
Wave Systems shares finished Monday at $3.42 and were up nearly 3% in the after-market session. The 50-day average daily share volume for Wave Systems is 842,000, according to the
shares were indicted higher after the company announced "encouraging" data from a pre-clinical study examining the subcutaneous delivery of rituximab, a therapeutic antibody that interferes with the development of cancer cells.
Using its proprietary NexACT drug delivery technology, NexMed said that animals receiving subcutaneous injections of rituximab in the study demonstrated a 46% enhancement in bioavailability over rituximab alone, which the company argues may open the door to improving the delivery of other therapeutic antibodies.
closed Monday at 40 cents and rose more than 10% in late trading. The 50-day average daily volume for NexMed is 3.9 million.
Advanced Battery Technologies
rose by 16 cents, or 4.8%, to $3.50 in the premarket session after the company posted a first-quarter profit of 11 cents a shar eon revenue of $19.53 million, above the single analyst estimate for a profit of 7 cents a share on revenue of $18.8 million. The 50-day average daily volume for Advanced Battery is 778,000.
On the other hand,
(ZAGG - Get Report)
fell nearly 9% in late trading Monday after the hand-held device accessory maker said it had first-quarter earnings of 3 cents a share on sales of $8.8 million, below the Thomson Reuters consensus for a profit of 4 cents a share on sales of $10.6 million. The 50-day average daily volume for Zagg is 245,000.
shares were poised to trade sharply higher above Monday's closing price of $3 after the jewelry retailer said it has closed on a new five-year, $150 million term loan with Golden Gate Capital. The private-equity firm will receive warrants that, if executed, would account for a 25% equity interest in Zale on a fully diluted basis.